Sechenov School
Home › Pathophysiology › Proliferation in Inflammation

Proliferation in Inflammation

Proliferatio

For medical students2 min readUpdated 2026-10-10

Proliferation is an obligatory component and the final stage of the inflammatory process, aimed at tissue repair. It consists of active cell division and the formation of extracellular matrix in the injury focus.

Essence of the processIncrease in the number of stromal and parenchymal cells, synthesis of extracellular matrix.
Main goalRegeneration of damaged elements and replacement of destroyed structures.
StimulatorsMitogens, inflammatory mediators, cytokines, and tissue breakdown products.
OutcomesComplete regeneration (restitution) or scar formation (substitution).

Essence and Objectives of the Proliferative Stage

Every inflammatory response follows a predictable progression, and proliferation (proliferatio) represents its final, concluding stage. It is important to understand that this is an absolute, obligatory component of the inflammatory mechanism without which tissue repair is impossible.

This stage is driven by two key processes occurring directly within the inflammation focus:

The ultimate goal of these cellular transformations boils down to two main tasks: the complete regeneration of altered (damaged) elements and the reliable replacement of tissue structures that were permanently destroyed during earlier stages of the pathological process.

Regulation of Cell Division

Proliferation does not happen spontaneously. Biologically active substances (BAS) play a crucial role in initiating and managing this process. Of particular importance are mitogens—specific factors that directly stimulate cell division.

Regulation is carried out by a complex network of factors affecting both stromal and parenchymal cells. They can be divided into several main groups:

Regulator GroupRepresentatives and Mechanism of Action
Inflammatory mediatorsBiogenic amines, kinins, and leukotrienes. They act as potent stimulators of cell division in the lesion focus.
CytokinesProduced by leukocytes and platelets. Include interleukins (IL), monokines, lymphokines, and various growth factors.
Destruction productsLow-molecular-weight peptides (putrescine, spermidine, spermine) and nucleic acid breakdown products. Released upon tissue destruction, they signal the growth of new structures.
HormonesInsulin, growth hormone (somatotropin), glucagon, thyroid hormones, and corticosteroids.
Other factorsTissue enzymes (hyaluronidase, collagenase), various ions, and neurotransmitters.

Feature of hormonal regulation: Hormones can either activate or suppress proliferation. The final effect strictly depends on their local concentration, intrinsic activity, and phenomena of synergism or antagonism. A striking example of this dualism is that mineralocorticoids actively stimulate regeneration, whereas glucocorticoids can inhibit it even at low doses.

Outcomes of Inflammation: Restitution and Substitution

The resolution of the inflammatory process and tissue repair can proceed via two different scenarios. The outcome depends directly on the initial volume of injury and the state of the organism.

  1. Complete regeneration (restitution). This is the optimal outcome, observed during a favorable course of inflammation. In this case, there is an exact replacement of all dead cells. Structural elements that suffered only reversible damage fully restore their integrity.
  2. Incomplete regeneration (substitution). This develops when there is significant, massive destruction of a tissue or organ. In this situation, the body must resort to defect replacement. Initially, granulation tissue forms at the site of destroyed elements. As it matures, it gradually condenses and transforms into a connective tissue scar.

Mnemonic

To remember the regulators of proliferation, use the abbreviation MC-PG (like heavy machinery rebuilding tissue): Mediators, Cytokines, Peptides (breakdown products), Growth factors/Hormones (Gormony in Russian).

Frequently asked questions

Which hormones stimulate proliferation during inflammation, and which inhibit it?

Hormonal regulation of proliferation during inflammation is multifaceted: hormones can either activate or suppress proliferation depending on concentration, activity, and synergism/antagonism.

  • Stimulatory action is noted for growth hormone (somatotropin), insulin, and thyroid hormones (thyroxine); sex steroids promote granulation tissue formation; mineralocorticoids activate regeneration.
  • Somatomedins—insulin-like growth factors synthesized under the influence of growth hormone: somatomedin C (IGF-1) and somatomedin A (IGF-2)—exert a direct stimulatory effect on cell proliferation.
  • Inhibitory action: low doses of glucocorticoids inhibit regeneration; glucocorticoids are also noted for suppressing fibroblast growth and division as well as collagen synthesis.
  • Glucagon is listed among regulatory hormones of proliferation that can either activate or suppress the process, though it is not highlighted separately as a pure stimulator or inhibitor in the sources.
Which specific growth factors (PDGF, TGF, FGF) participate in regulating proliferation?

The sources explicitly mention the following growth factors involved in regulating proliferation:

  • Platelet-derived growth factor (PDGF): released by platelets during degranulation; IL-1 stimulates PDGF release; PDGF activates fibroblasts, which synthesize extracellular matrix components—collagen, fibronectin, and glycosaminoglycans. PDGF is also listed among growth factors produced by infiltrating and resident cells during inflammatory glomerular injury.
  • Transforming growth factor beta (TGF-β): released by platelets during degranulation; immune cells secrete TGF-β as a profibrotic cytokine; TGF-β is indicated among growth factors in inflammatory glomerular injury.
  • Fibroblast growth factor (FGF): produced by macrophages; mast cells synthesize FGF upon stimulation. Fibroblast growth factors are listed among growth factors that stimulate proliferation.

Additionally, epidermal growth factor, nerve growth factor, and insulin-like growth factors are mentioned among growth factors associated with proliferation stimulation.

What main components (collagen, GAGs, etc.) form the new extracellular matrix during repair?

During repair in the proliferative stage, extracellular matrix is formed in the inflammation focus. The sources explicitly name the following extracellular matrix components:

  • Collagen, including stromal type I and III collagens, intensively produced by fibroblasts;
  • Fibronectin, intensively produced by fibroblasts;
  • Glycosaminoglycans—components of the extracellular matrix synthesized by activated fibroblasts.

PDGF-activated fibroblasts synthesize extracellular matrix components: collagen, fibronectin, and glycosaminoglycans.

Which specific interleukins (numbers) act as main stimulators of fibroblasts during proliferation?

Among interleukins explicitly credited with stimulating fibroblasts, interleukin-1 (IL-1) is named.

  • Endothelial cells synthesize IL-1; immune cells also secrete IL-1.
  • IL-1 enhances fibroblast proliferation.
  • IL-1 stimulates the release of PDGF, and PDGF activates fibroblasts, which synthesize extracellular matrix components.

Additionally, IL-1 and IL-2 through IL-7 are listed as cytokine activators of proliferation overall.

Is proliferation an obligatory stage of inflammation?

Yes, it is an absolute and obligatory component of the inflammatory mechanism. Without it, the completion of the process and repair of damaged tissue are impossible.

How do hormones affect cell division in the focus of inflammation?

The effect depends on the type of hormone, its concentration, and synergy with other substances. For example, mineralocorticoids stimulate regeneration, whereas glucocorticoids inhibit it even at low doses.

What happens during significant organ destruction?

Incomplete regeneration (substitution) develops. The defect is filled with young granulation tissue, which matures into a connective tissue scar.

Go deeper

More topics in Pathophysiology

Gastroesophageal Reflux DiseaseAcromegaly and GigantismDisorders of Final Stages of Protein CatabolismChromosomal DisordersPathological Process, Reaction, and StateCellular Dystrophies (Degenerations)Fever in ChildrenMechanisms of the Infectious ProcessDiabetic NephropathyDyslipoproteinemiasPathogenesis of EdemaHyperphosphatemiaPathophysiology →